# A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents

> **NCT02517892** · NA · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 1500 (actual)

## Conditions studied

- Metastatic Oncogen-driven Cancer

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT02517892
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-18
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517892, "A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02517892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*